Advus Financial Partners’s AbbVie ABBV Stock Holding History

Advus Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$498K	Sell	1,902 -568	-23%	-$146K	0.14%	89
2026 Q2	$621K	Buy	2,470 +1,354	+121%	+$291K	0.18%	79
2026 Q1	$243K	Hold	1,116	–	–	0.09%	64
2025 Q4	$255K	Buy	1,116 +200	+22%	+$45.6K	0.09%	60
2025 Q3	$212K	Buy	+916	New	+$187K	0.08%	63
2024 Q2	–	Sell	-1,292	Closed	-$235K	–	60
2024 Q1	$235K	Hold	1,292	–	–	0.1%	57
2023 Q4	$200K	Buy	+1,292	New	+$188K	0.1%	53
2021 Q4	–	Sell	-2,695	Closed	-$365K	–	47
2021 Q3	$365K	Buy	+2,695	New	+$308K	0.2%	60

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Advus Financial Partners's ABBV Position: Q3 2026 in Review

Advus Financial Partners reduced its AbbVie (ABBV) stake by 23% in Q3 2026, selling an estimated $146K and leaving 1,902 shares worth $498K. The position accounts for 0.14% of the portfolio, ranked #89.

Advus Financial Partners first reported a position in ABBV in Q3 2021 and has held it in 8 quarters since. The position peaked at $621K in Q2 2026. 2,862 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Advus Financial Partners held 1,902 shares of AbbVie worth $498K as of Q3 2026.
Advus Financial Partners sold 568 AbbVie shares in Q3 2026, an estimated $146K.
AbbVie made up 0.14% of Advus Financial Partners's portfolio in Q3 2026, its #89 holding.
Advus Financial Partners first reported a position in AbbVie in Q3 2021 and has held it in 8 quarters since.
Advus Financial Partners's AbbVie position peaked at $621K in Q2 2026.
2,862 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Advus Financial Partners's 13F filing for Q3 2026, filed 20 Oct 2026.